Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations now appear under the study details with a Washington site listed. The page update changes the revision from v3.3.2 to v3.3.3 and removes the Washington Locations and HHS Vulnerability Disclosure items from the footer area.
    Difference
    0.2%
    Check dated 2025-12-23T09:46:59.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown, replacing the previous v3.3.1 revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:41:09.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Site revision updated from v3.2.0 to v3.3.1 with no changes to study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:11:34.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The funding/operating-status notice was removed from the page, eliminating information about potential data delays and NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:30:20.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The screenshots show minor UI/layout changes on the study page without changing core study details such as eligibility criteria, endpoints, or status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:14:59.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The page has been updated to include a notice about government funding impact and an updated version tag from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:04:59.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.